Homologous Recombinant Deficiency near me in Asansol

Homologous Recombinant Deficiency (HRD) testing with therapy selection is a molecular diagnostic test that identifies genetic alterations or deficiencies in DNA repair pathways, specifically in genes involved in homologous recombination. HRD testing assesses genomic scars or abnormalities associated with HRD, aiding in the selection of appropriate targeted therapies. This test helps guide treatment decisions by identifying patients who may benefit from therapies targeting HRD, such as PARP inhibitors. By assessing HRD status, the test enables personalized therapy selection, improving treatment outcomes in cancers like ovarian, breast, and prostate cancer.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.